Engineers Gate Manager’s CTI BioPharma Corp. (DE) Common Stock CTIC Stock Holding History

Engineers Gate Manager’s Portfolio CTIC Stock Details CTIC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-15,226	Closed	-$63.9K	–	2133
2023 Q1	$63.9K	Sell	15,226 -490	-3%	-$2.54K	﹤0.01%	1544
2022 Q4	$94.5K	Sell	15,716 -10,781	-41%	-$58.8K	0.01%	1497
2022 Q3	$154K	Buy	+26,497	New	+$165K	0.01%	1384

Other funds holding CTIC

UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return

Legal & General Group London, United Kingdom $432B AUM 29.4% 1-Year Est. Return

Engineers Gate Manager's CTIC Position: Q2 2023 in Review

Engineers Gate Manager sold out of CTI BioPharma Corp. (DE) Common Stock (CTIC) in Q2 2023, closing a stake of 15,226 shares — an estimated $63.9K sold.

Engineers Gate Manager first reported a position in CTIC in Q3 2022 and held it in 3 quarters. The position peaked at $154K in Q3 2022. 2 funds tracked by Wall St. Rank hold CTIC as of Q2 2023.

Engineers Gate Manager reported no remaining CTI BioPharma Corp. (DE) Common Stock position as of Q2 2023 after selling out during the quarter.
Engineers Gate Manager sold 15,226 CTI BioPharma Corp. (DE) Common Stock shares in Q2 2023, an estimated $63.9K.
Engineers Gate Manager first reported a position in CTI BioPharma Corp. (DE) Common Stock in Q3 2022 and held it in 3 quarters.
Engineers Gate Manager's CTI BioPharma Corp. (DE) Common Stock position peaked at $154K in Q3 2022.
2 funds tracked by Wall St. Rank held CTI BioPharma Corp. (DE) Common Stock as of Q2 2023.

Based on Engineers Gate Manager's 13F filing for Q2 2023, filed 14 Aug 2023.